ScandiDos AB is a Sweden-based company active within the medical equipment sector. The Company's competence includes the design and development of radiation detectors, electrometers and application software, as well as clinical experience in medical physics and radiation measurements. The Company's business focuses on developing such applications as Arc Therapy - IMAT/VMAT, Tomotherapy, IMRT and Machine QA, among others. ScandiDos AB markets its products under the Delta4 brand. Delta4 offers Delta4AT - At Treatment in-vivo dosimetry for advanced RT and Delta4PT - Pre Treatment volumetric plan QA, among others. It operates in Europe, Asia, North America and Asia, and through numerous distributors and subsidiaries, including Additec GmbH and Conmedica GmbH in Germany, and ScandiDos SAS in France.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Market Cap	55.87M 5.85M 5.09M 4.7M 4.42M 8.26M 551M 8.32M 21.7M 272M 21.95M 21.48M 941M	P/E 2024	-5.36x	P/E 2025	221x
Enterprise Value	45.81M 4.79M 4.18M 3.85M 3.62M 6.78M 452M 6.82M 17.79M 223M 18M 17.61M 772M	EV / Sales 2024	1.23x	EV / Sales 2025	0.97x
Free-Float	25.71%	Yield 2024 *	-	Yield 2025	-

06-17	ScandiDos AB Reports Earnings Results for the Fourth Quarter and Full Year Ended April 30, 2026	CI
06-02	Affärsvärlden maintains buy rating on Elekta despite earnings disappointment	FW
05-15	ScandiDos AB Unveils Delta4 SRS Pro at ESTRO 2026	CI
05-06	ScandiDos AB Announces CEO Changes	CI
03-18	Scandidos Q3 net sales SEK 13.7 mln	RE
03-18	ScandiDos AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2026	CI
12-16	ScandiDos AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2025	CI
18/09/25	ScandiDos AB Reports Earnings Results for the First Quarter Ended July 31, 2025	CI
18/09/25	Scandidos Q1 net sales SEK 11.5 million	RE
18/06/25	ScandiDos AB Reports Earnings Results for the Full Year Ended April 30, 2025	CI
18/06/25	Scandidos Q4 EBITDA At SEK -0.2 Mln	RE
12/03/25	Scandidos Q3 Net Sales SEK 17.7 Mln	RE
12/03/25	ScandiDos AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2025	CI

06-02	Affärsvärlden maintains buy rating on Elekta despite earnings disappointment	FW
21/12/23	Affärsvärlden sets a buy recommendation for Scandidos	FW
01/06/23	Business World gives a neutral advice for Scandidos	FW

05-15	ScandiDos Unveils Delta4 SRS Pro at ESTRO 2026: Setting a New Standard for Stereotactic QA	AQ
05-06	Anders Murman appointed Acting CEO of ScandiDos	AQ
21/11/24	ScandiDos Expands with New Reference Center in Madrid, Spain	AQ
18/04/24	Successful user meeting in Madrid highlights ScandiDos' innovative solutions	AQ
20/12/23	ScandiDos receives orders worth €478 000 from China	AQ

Manager	Title	Age	Since
Anders Murman CEO	Chief Executive Officer	59	06/05/2026
Görgen Ingmar Nilsson CEO	Chief Executive Officer	66	01/03/2001
Henriette Münch DFI	Director of Finance/CFO	46	01/12/2021

ScandiDos AB (publ) Stock OTC Markets

Stocks

SDOSF

SE0005768124

Advanced Medical Equipment & Technology

Valuation: ScandiDos AB (publ)

Latest news : ScandiDos AB (publ)

Analysts' recommendations: ScandiDos AB (publ)

Press Releases: ScandiDos AB (publ)

Managers and Directors: ScandiDos AB (publ)

Medical Diagnostic & Testing Equipment

Financials

Company Profile

Director	Title	Age	Since
Tom Åke Sundelin BRD	Director/Board Member	61	01/10/2018
Björn Åke Fredric Eliasson BRD	Director/Board Member	58	01/01/2021
Bo Fredrik Ljungberg CHM	Chairman	56	01/10/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SCANDIDOS AB (PUBL)	-.--%	-.--%	-	-	5.06M
SARTORIUS AG	-4.86%	-5.77%	+3.63%	-28.26%	16.46B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	-2.00%	-0.17%	+23.54%	+48.91%	1.6B
ECKERT & ZIEGLER SE	+2.04%	+0.65%	-28.49%	+22.93%	1.1B
QUIDELORTHO CORPORATION	+2.02%	-5.18%	-52.84%	-84.70%	895M
CONTEC MEDICAL SYSTEMS CO.,LTD	+5.56%	+5.17%	-17.21%	-51.84%	642M
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	+0.58%	-1.45%	-42.04%	-58.31%	551M
VAREX IMAGING CORPORATION	+3.63%	-4.44%	+37.42%	-54.07%	430M
REVENIO GROUP OYJ	-1.26%	-1.88%	-53.89%	-62.18%	391M
CELLAVISION AB	-3.12%	+4.11%	-26.69%	-23.58%	358M
Average	+0.29%	+0.32%	-17.40%	-32.34%	2.49B
Weighted average by Cap.	-3.39%	-2.73%	-1.34%	-24.90%

	2024	2025
Net sales	62.54M 6.55M 5.7M 5.26M 4.94M 9.25M 617M 9.32M 24.29M 304M 24.57M 24.04M 1.05B	64.01M 6.7M 5.84M 5.38M 5.06M 9.47M 631M 9.53M 24.86M 311M 25.14M 24.6M 1.08B
Net income	-14.65M -1.53M -1.34M -1.23M -1.16M -2.17M -144M -2.18M -5.69M -71.19M -5.75M -5.63M -247M	327K 34.22K 29.82K 27.48K 25.85K 48.37K 3.23M 48.7K 127K 1.59M 128K 126K 5.51M
Net Debt	-1.53M -160K -140K -129K -121K -226K -15.1M -228K -595K -7.44M -601K -588K -25.79M	-10.06M -1.05M -917K -845K -795K -1.49M -99.19M -1.5M -3.91M -48.88M -3.95M -3.87M -169M